← Leaderboards
Gary H Cohen
University Of Pennsylvania
$11,413,390
Attributed
$12,979,477
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$12,979,477 · 9
By mechanism
R37$3,907,148 · 1
R01$3,764,984 · 1
U54$2,064,975 · 1
R44$1,503,302 · 1
R21$475,500 · 1
P01$375,963 · 1
Top collaborators
- Benjamin Delbert Brooks4 shared
- Roselyn J. Eisenberg3 shared
- Chris Bailey-Kellogg2 shared
- David G. Myszka2 shared
- Harvey Michael Friedman1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Harvey Michael Friedman$28,257,678
- Stuart N. Isaacs$9,020,266
- Robert Paul Ricciardi$14,439,000
- Robert H. Silverman$18,272,403
- Julie Johnston$7,919,588
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusGlycoproteinsStructureCellsReceptor CellComplexReceptorVirionProteinsSimplexvirusCollaborationsVaccinesEventInfectionBinding (Molecular Function)TechnologyCell FusionReceptor BindingBaseBiosensorVirus EnvelopeVirus ProteinVaccine DevelopmentMonoclonal Antibodies
Grant awards (36)
Functions of HSV glycoproteins in virus entry and the humoral immune response$400,000
R01 · FY2019 · AI · contact PI
Improving HSV-2 vaccine efficacy by focusing antibody epitope coverage.$284,815
R41 · FY2019 · AI
Functions of HSV glycoproteins in virus entry and the humoral immune response$400,000
R01 · FY2018 · AI · contact PI
Improving vaccine development through high-throughput immunogenicity screening.$751,389
R44 · FY2017 · AI
Functions of HSV glycoproteins in virus entry and the humoral immune response$400,000
R01 · FY2017 · AI · contact PI
High-throughput, multiplexed characterization and modeling of antibody:antigen binding, with application to HSV$299,999
R43 · FY2017 · AI
Improving vaccine development through high-throughput immunogenicity screening.$751,913
R44 · FY2016 · AI
Functions of HSV glycoproteins in virus entry and the humoral immune response$400,000
R01 · FY2016 · AI · contact PI
Functions of HSV glycoproteins in virus entry and the humoral immune response$200,000
R01 · FY2015 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$389,983
R37 · FY2014 · AI · contact PI
Mechanisms of poxvirus entry into cells$371,771
U54 · FY2013 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$366,748
R37 · FY2013 · AI · contact PI
Mechanisms of poxvirus entry into cells$429,647
U54 · FY2012 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$390,328
R37 · FY2012 · AI · contact PI
Mechanisms of poxvirus entry into cells$423,073
U54 · FY2011 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$390,103
R37 · FY2011 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$519,399
R37 · FY2010 · AI · contact PI
Mechanisms of poxvirus entry into cells$427,944
U54 · FY2010 · AI · contact PI
Mechanisms of poxvirus entry into cells$412,540
U54 · FY2009 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$362,581
R37 · FY2009 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$362,581
R37 · FY2008 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$369,604
R37 · FY2007 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$380,643
R37 · FY2006 · AI · contact PI
Studies of Herpes Simplex Virus Glycoproteins$375,178
R37 · FY2005 · AI
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS$396,250
R01 · FY2004 · AI
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS$396,250
R01 · FY2003 · AI
Development of therapeutic antibodies for vaccinia virus$237,750
R21 · FY2003 · AI
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS$356,625
R01 · FY2002 · AI
Development of therapeutic antibodies for vaccinia virus$237,750
R21 · FY2002 · AI
CORE--BACULOVIRUS$103,525
P01 · FY2002 · NS
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS$396,250
R01 · FY2001 · AI
DETERMINATION OF OLIGOMERIC STATE OF HSV GLYCOPROTEINS GD, GH &GL, USING STEM$293,069
P41 · FY2001 · RR
CORE--BACULOVIRUS$103,525
P01 · FY2001 · NS
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS$419,609
R01 · FY2000 · AI
CORE--BACULOVIRUS$168,913
P01 · FY2000 · NS
DETERMINATION OF OLIGOMERIC STATE OF HSV GLYCOPROTEINS GD, GH &GL, USING STEM$9,722
P41 · FY2000 · RR